urea has been researched along with Nervous System Diseases in 27 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reported successes in the treatment of hyponatremia due to SIADH by administration of urea and normal saline led to the authors' routine use of this therapy for hyponatremic neurosurgical patients." | 5.28 | Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. ( Harbaugh, RE; Reeder, RF, 1989) |
| "We studied 26 children with inborn errors of urea synthesis who survived neonatal hyperammonemic coma." | 3.67 | Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. ( Batshaw, ML; Brusilow, SW; Mellits, ED; Msall, M; Suss, R, 1984) |
| "Omecamtiv mecarbil (OM) is a selective small molecule activator of cardiac myosin that prolongs myocardial systole and increases stroke volume without apparent effects on myocardial oxygen demand." | 1.72 | Omecamtiv mecarbil treatment improves post-resuscitation cardiac function and neurological outcome in a rat model. ( Chen, WJ; Huang, CH; Tsai, MS; Wu, SN, 2022) |
| "The objective is to investigate coronavirus disease 2019 (COVID-19)-associated neurological and psychiatric effects and explore possible pathogenic mechanisms." | 1.72 | Neurological and psychiatric presentations associated with COVID-19. ( He, X; Hu, X; Pan, K; Yu, H; Zhang, D; Zhang, G; Zhang, L; Zheng, X, 2022) |
| "Reported successes in the treatment of hyponatremia due to SIADH by administration of urea and normal saline led to the authors' routine use of this therapy for hyponatremic neurosurgical patients." | 1.28 | Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. ( Harbaugh, RE; Reeder, RF, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, SN | 1 |
| Tsai, MS | 1 |
| Huang, CH | 1 |
| Chen, WJ | 1 |
| He, X | 1 |
| Zhang, D | 1 |
| Zhang, L | 2 |
| Zheng, X | 1 |
| Zhang, G | 1 |
| Pan, K | 1 |
| Yu, H | 1 |
| Hu, X | 1 |
| Mondal, P | 1 |
| Trigun, SK | 1 |
| Anstey, JR | 1 |
| Haydon, TP | 1 |
| Ghanpur, RB | 1 |
| de Jong, G | 1 |
| Posset, R | 1 |
| Garcia-Cazorla, A | 1 |
| Valayannopoulos, V | 1 |
| Teles, EL | 1 |
| Dionisi-Vici, C | 1 |
| Brassier, A | 1 |
| Burlina, AB | 1 |
| Burgard, P | 1 |
| Cortès-Saladelafont, E | 1 |
| Dobbelaere, D | 1 |
| Couce, ML | 1 |
| Sykut-Cegielska, J | 1 |
| Häberle, J | 1 |
| Lund, AM | 1 |
| Chakrapani, A | 1 |
| Schiff, M | 1 |
| Walter, JH | 1 |
| Zeman, J | 1 |
| Vara, R | 1 |
| Kölker, S | 1 |
| TATLOW, WF | 1 |
| Durukan, P | 1 |
| Ozkan, S | 1 |
| Ikizceli, I | 1 |
| Vardar, A | 1 |
| Ipekci, A | 1 |
| Duman, A | 1 |
| SZENTKIRALYI, E | 1 |
| KOVACS, F | 1 |
| SZEGOE, V | 1 |
| DEAK, E | 1 |
| HANKO, Z | 1 |
| Singh, RH | 1 |
| Gropman, AL | 1 |
| Summar, M | 1 |
| Leonard, JV | 1 |
| Msall, M | 1 |
| Batshaw, ML | 1 |
| Suss, R | 1 |
| Brusilow, SW | 1 |
| Mellits, ED | 1 |
| Matsumura, R | 1 |
| Funck-Brentano, JL | 1 |
| Man, NK | 1 |
| Sausse, A | 1 |
| Cueille, G | 1 |
| Zinfraff, J | 1 |
| Drueke, T | 1 |
| Jungers, P | 1 |
| Billon, JP | 1 |
| Nagata, N | 1 |
| Matsuda, I | 1 |
| Matsuura, T | 1 |
| Oyanagi, K | 1 |
| Tada, K | 1 |
| Narisawa, K | 1 |
| Kitagawa, T | 1 |
| Sakiyama, T | 1 |
| Yamashita, F | 1 |
| Yoshino, M | 1 |
| Nagata, H | 1 |
| Brimijoin, S | 1 |
| Low, P | 1 |
| Schmelzer, JD | 1 |
| Reeder, RF | 1 |
| Harbaugh, RE | 1 |
| Patt, A | 1 |
| Harken, AH | 1 |
| Burton, LK | 1 |
| Rodell, TC | 1 |
| Piermattei, D | 1 |
| Schorr, WJ | 1 |
| Parker, NB | 1 |
| Berger, EM | 1 |
| Horesh, IR | 1 |
| Terada, LS | 1 |
| Minetti, L | 1 |
| Civati, G | 1 |
| Guastoni, C | 1 |
| Perego, A | 1 |
| Teatini, U | 1 |
| Morris-Jones, PH | 1 |
| Houston, IB | 1 |
| Evans, RC | 1 |
| Druckrey, H | 1 |
| Schagen, B | 1 |
| Ivankovic, S | 1 |
| Losowsky, MS | 1 |
| Scott, BB | 1 |
| Port, FK | 1 |
| Johnson, WJ | 1 |
| Klass, DW | 1 |
| O'Reilly, S | 1 |
| Chen, FC | 1 |
| Cavanagh, JB | 1 |
| Prill, A | 1 |
| Pericoli, F | 1 |
| Hopkins, IJ | 1 |
| Connelly, JF | 1 |
| Hocking, B | 1 |
| Maddison, TG | 1 |
4 reviews available for urea and Nervous System Diseases
| Article | Year |
|---|---|
Nutritional management of patients with urea cycle disorders.
Topics: Adolescent; Adult; Ammonia; Child; Child, Preschool; Diet Therapy; Enzymes; Female; Humans; Hyperamm | 2007 |
Neurological implications of urea cycle disorders.
Topics: Ammonia; Brain; Cognition; Enzymes; Female; Humans; Hyperammonemia; Magnetic Resonance Imaging; Male | 2007 |
[Disorders of the urea cycle].
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Arginine; Argininosuccinic Acid; Citrullinemia; Human | 2000 |
Hepatic encephalopathy.
Topics: Acetazolamide; Ammonia; Constipation; Diet Therapy; Electroencephalography; Gastrointestinal Hemorrh | 1973 |
23 other studies available for urea and Nervous System Diseases
| Article | Year |
|---|---|
Omecamtiv mecarbil treatment improves post-resuscitation cardiac function and neurological outcome in a rat model.
Topics: Animals; Cardiopulmonary Resuscitation; Heart Arrest; Male; Myocardial Contraction; Nervous System D | 2022 |
Neurological and psychiatric presentations associated with COVID-19.
Topics: C-Reactive Protein; China; COVID-19; Cystatin C; Humans; Interleukin-10; Mental Disorders; Nervous S | 2022 |
Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.
Topics: Ammonia; Brain; Connexins; Energy Metabolism; Glutamic Acid; Heart Arrest; Hepatic Encephalopathy; H | 2014 |
Initial presentation of a urea cycle disorder in adulthood: an under-recognised cause of severe neurological dysfunction.
Topics: Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Male; Nervous System Diseases; Severity | 2015 |
Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Ammonium Compounds; Argininosuccinate Synthase; Ch | 2016 |
Acute purpura with neurological complications associated with sedormid therapy.
Topics: Humans; Nervous System Diseases; Purpura; Urea | 1948 |
Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography.
Topics: Contrast Media; Creatinine; Emergency Medical Services; Female; Glomerular Filtration Rate; Health S | 2012 |
[TREATMENT OF CEREBRAL EDEMA WITH UREA SOLUTION IN ACUTE NEUROINFECTIONS].
Topics: Brain Edema; Encephalitis; Humans; Meningitis; Nervous System Diseases; Pharmaceutical Solutions; Ur | 1965 |
Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Argininosuccinate Synthase; Argininosuccinic Aciduria | 1984 |
Neuropathy and "middle" molecule toxins.
Topics: Adult; Chromatography, Gel; Female; Humans; Kidneys, Artificial; Male; Middle Aged; Molecular Weight | 1975 |
Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.
Topics: Brain; Child, Preschool; Electroencephalography; Enzymes; Humans; Infant; Infant, Newborn; Intellige | 1991 |
Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea.
Topics: Animals; Axonal Transport; Hypoxia; Male; Motor Neurons; Nerve Tissue Proteins; Nervous System Disea | 1987 |
Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients.
Topics: Blood Urea Nitrogen; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Nerv | 1989 |
Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains.
Topics: Allopurinol; Animals; Brain; Brain Chemistry; Brain Edema; Brain Ischemia; Female; Gerbillinae; Hydr | 1988 |
Minimal standards for hemofiltration.
Topics: Blood; Blood Pressure; Body Weight; Creatinine; Humans; Kidney Failure, Chronic; Nervous System Dise | 1985 |
Prognosis of the neurological complications of acute hypernatraemia.
Topics: Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Humans; Hypernatremia; I | 1967 |
[Induction of neurogenic malignancies by one single dose of ethyl-nitrosourea (ENU) given to newborn and juvenile BD IX-strain rats].
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Body Weight; Carcinogens; Disease Mode | 1970 |
Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate.
Topics: Acute Kidney Injury; Adolescent; Adult; Blood Pressure; Body Weight; Chlorides; Electroencephalograp | 1973 |
Neurologic disorders and liver disease.
Topics: Adipose Tissue; Ammonia; Brain Diseases; Citrulline; Fatty Liver; Galactosemias; Hepatic Encephalopa | 1971 |
Factors affecting neurotoxicity by p-bromophenylacetylurea in rats.
Topics: Acetylcholinesterase; Age Factors; Animals; Biotransformation; Carbon Tetrachloride Poisoning; Chemi | 1971 |
[The value of the blood brain barrier in the pathogenesis of neurologic diseases in extraneural metabolism disorders--example of kidney insufficiency].
Topics: Acute Kidney Injury; Blood-Brain Barrier; Creatinine; Humans; Kidney Failure, Chronic; Nervous Syste | 1970 |
[Hepatic encephalopathy and its therapy with lactulose].
Topics: Ammonia; Disaccharides; Electroencephalography; Encephalitis; Humans; Hydrogen-Ion Concentration; Li | 1971 |
Neurological abnormalities in primary hyperammonaemia.
Topics: Ammonia; Diet Therapy; Dietary Proteins; Female; Humans; Infant; Intellectual Disability; Lysine; Me | 1968 |